Top Artificial Intelligence-Based Healthcare Mobile Apps and Their Use Cases

Articles

How Will Emerging Therapies Drift the Amyotroph...

Mitsubishi replacing RADICAVA’s Intravenous (IV) formulation with Oral. Opinion on Amylyx Pharma’s recent approval, RELYVRIO  The amyotrophic lateral sclerosis treatment landscape is stringent...

Nov 04, 2022

clinical-diagnostics-market-outlook
Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market

Clinical Diagnosis (Dx) is the identification and confirmation of disease or disorder or exposure to xenobiotics to explain the clinical manifestations shown by the patient. It is also performed to assess the state of health of an individual (routine health checkup), functioning of any organ or associated metabolic...

Find More
humira-biosimilars-in-psoriatic-arthritis-treatment-market
HUMIRA Biosimilars in the US: The Talk of the Psoriatic Arthritis Treatment Market

Psoriatic arthritis (PsA) is a type of chronic inflammatory arthritis that affects approximately 1 in every 10 people with psoriasis. According to the National Psoriasis Foundation, psoriasis is most common in adults aged 30 to 50. However, psoriatic arthritis can develop at any age, including children. Accordin...

Find More
non-opioid-analgesics-for-chronic-pain-treatment
Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients

Chronic pain is the leading cause of adult disability in the United States. Approximately 50 million Americans are currently suffering from chronic pain. The most common sources of chronic pain are lower back problems, arthritis, cancer, RSDS, repetitive stress injuries, shingles, headaches, and fibromyalgia. Other...

Find More

More Views & Analysis

alpha-1-antitrypsin-deficiency-treatment-market
Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market

In the 21st century, public health has yielded major advances in understanding and managing diseases. Sometimes, early diagnosis remains crucial in managing and treating a serious condition. One such rare genetic disorder, alpha-1 antitrypsin deficiency (AATD), has witnessed improvements concerning awareness and co...

Find More

Emerging Trends and Technologies in the Dental Care Market
Evaluating the Key Trends and Technologies Shaping the Future of Dentistry

Oral diseases, while largely preventable, are one of the major health burdens globally and affect about 3.5 billion people. Dental caries or cavities (commonly known as tooth decay) and gum (periodontal) disease are the most common conditions that severely affect oral health and account for the most considerable pa...

Find More

oncolytic-viruses-for-cancer-treatment
Oncolytic Viruses: Can Be The Next Frontier in Cancer Immunotherapy?

Oncolytic viruses are cancer treatments that employ a natural or reprogrammed virus capable of targeting and killing malignant cells. They are a new class of cancer agents that induce tumor regression by causing immunogenic cell death, inducing preferential replication in tumor cells, and stimulating host antitumor...

Find More

checkpoint-inhibitors-for-refractory-cancer-treatment
Checkpoint Inhibitors: A Potential Approach in the Fight Against Refractory Cancer

Immune checkpoint inhibitors are drugs that inhibit immune checkpoints. These drugs allow immune cells to respond more strongly to cancer by blocking them. This blocks the “off” signal, allowing T-cells to kill cancer cells. Checkpoint inhibitors can be used to treat a variety of cancers, including lung cancer (...

Find More

pcsk9-inhibitors-for-cholesterol-management
PCSK9 Inhibitors: A New Era for Cholesterol Management

Proprotein convertase subtilisin/Kexin type 9 (PCSK9) affects LDL receptor degradation and decreases the clearance of circulating LDL particles, which is crucial in cholesterol metabolism. PCSK9 is predominantly generated by hepatocytes, with additional sources including the intestines and kidneys. PCSK9 reduces LD...

Find More

peripheral-t-cell-lymphoma-treatment-market
Peripheral T-cell Lymphoma Treatment Market: How are Pipeline Therapies Reshaping the Therapeutic Outlook?

Peripheral T-cell Lymphoma (PTCL) is a diverse disorder category that accounts for 10% to 15% of non-Hodgkin lymphomas. Most PTCL subtypes, including PTCL-NOS, AITL, ALCL, enteropathy-type T-cell lymphoma, and extranodal natural killer (NK) cell/T-cell lymphoma, are aggressive (fast-growing) lymphomas. PTCLs are...

Find More

Molluscum contagiosum is an inflammation of the skin that is caused by the poxvirus Molluscum contag.....

Find More

Lamellar Ichthyosis (LI) is an autosomal recessive congenital Ichthyosis (ARCI), which mainly affect.....

Find More

Hemophilia, a genetic bleeding disorder characterized by a clotting factor protein deficiency. Intak.....

Find More

Well, MDS being one of the rare blood cancers, has been into the limelight of researchers since a de.....

Find More

Nestlé and Unilever are multinational corporations established in 1866 and 1930, respectively. The .....

Find More

An autoimmune disease in which the immune system attacks its healthy skin, Cutaneous Lupus Erythemat.....

Find More